Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

Abstract Background Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction. Methods To assess the incidence and the spectrum of endocrinopathies in melanoma patients...

Full description

Bibliographic Details
Main Authors: Eva Kassi, Anna Angelousi, Nikolaos Asonitis, Panagiotis Diamantopoulos, Amalia Anastasopoulou, George Papaxoinis, Michalis Kokkinos, Ilias Giovanopoulos, Georgios Kyriakakis, Fotini Petychaki, Akrivi Savelli, Olga Benopoulou, Helen Gogas
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Cancer Medicine
Subjects:
checkpoint inhibitor
endocrinopathies
hypophysitis
melanoma
thyroid
Online Access:https://doi.org/10.1002/cam4.2533

Internet

https://doi.org/10.1002/cam4.2533

Similar Items